World's Best Scientists 2026 revealed!

Overview

Barbara J. B. Johnson is affiliated with the Centers for Disease Control and Prevention in the United States. Their research spans multiple fields primarily focused on medicine, with notable contributions in biochemistry, genetics, and molecular biology.

Their recent publications include the following papers:

  • A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1 (2021) published in Clinical Cancer Research
  • A New Method for Improving Extraction Efficiency and Purity of Urine and Plasma Cell-Free DNA (2021) published in Diagnostics
  • A new method for improving extraction efficiency and purity of urine and plasma cell-free DNA (2021) published in bioRxiv (Cold Spring Harbor Laboratory)
  • Girls only science classes in a coeducation school: a case study (2021) published in OPAL (Open@LaTrobe) (La Trobe University)

Frequent coauthors working alongside Barbara J. B. Johnson include:

  • Selena Y. Lin
  • Luo Yue
  • Sung R. Park
  • Zhili Wang
  • Ying-Hsiu Su

Their work has been published in venues such as:

  • Clinical Cancer Research
  • Diagnostics
  • bioRxiv (Cold Spring Harbor Laboratory)
  • OPAL (Open@LaTrobe) (La Trobe University)

Main fields of study for Barbara J. B. Johnson include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of particular focus are:

  • Oncology
  • Pediatrics, Perinatology and Child Health
  • Cancer Research
  • Psychiatry and Mental health
  • Molecular Biology

Barbara J. B. Johnson works on topics covering:

  • Prenatal Screening and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Cancer, Stress, Anesthesia, and Immune Response
  • Viral-associated cancers and disorders
  • Molecular Biology Techniques and Applications

Best Publications

  • Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

    Maureen Howard;John Farrar;Mary Hilfiker;Barbara Johnson

  • Lyme Disease Testing by Large Commercial Laboratories in the United States

    Alison F. Hinckley;Neeta P. Connally;James I. Meek;Barbara J. Johnson

  • Sensitive and Specific Serodiagnosis of Lyme Disease by Enzyme-Linked Immunosorbent Assay with a Peptide Based on an Immunodominant Conserved Region of Borrelia burgdorferi VlsE

    Fang Ting Liang;Allen C. Steere;Adriana R. Marques;Barbara J. B. Johnson

  • Serodiagnosis of Lyme Disease by Kinetic Enzyme-Linked Immunosorbent Assay Using Recombinant VlsE1 or Peptide Antigens of Borrelia burgdorferi Compared with 2-Tiered Testing Using Whole-Cell Lysates

    Rendi Murphree Bacon;Brad J. Biggerstaff;Martin E. Schriefer;Robert D. Gilmore

  • Identification of a 47 kDa fibronectin‐binding protein expressed by Borrelia burgdorferi isolate B31

    William S. Probert;Barbara J. B. Johnson

  • Borrelia lonestari Infection after a Bite by an Amblyomma americanum Tick

    Angela M. James;Dionysios Liveris;Gary P. Wormser;Ira Schwartz

  • Amblyomma americanum: a potential vector of human ehrlichiosis.

    Burt E. Anderson;Kimetha G. Sims;James G. Olson;James E. Childs

  • The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83.

    Richard M. Kinney;Barbara J.B. Johnson;Jacqueline B. Welch;Kiyotaka R. Tsuchiya

  • Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation.

    Maureen Howard;Steven B. Mizel;Lawrence Lachman;John Ansel

  • Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone

    Nancy L. Davis;Nathaniel Powell;Gary F. Greenwald;Loretta V. Willis

  • Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.

    R D Gilmore;K J Kappel;M C Dolan;T R Burkot

  • Duration of Tick Attachment as a Predictor of the Risk of Lyme Disease in an Area in which Lyme Disease Is Endemic

    Sunil K. Sood;Mark B. Salzman;Barbara J. B. Johnson;Christine M. Happ

  • Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial.

    Daina Vanags;Bronwyn Williams;Barbara Johnson;Stephen Hall

  • Heat Shock Protein 10 Inhibits Lipopolysaccharide-induced Inflammatory Mediator Production

    Barbara J. Johnson;Thuy T.T. Le;Caroline A. Dobbin;Tatjana Banovic

  • Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease

    Gary P. Wormser;Martin Schriefer;Maria E. Aguero-Rosenfeld;Andrew Levin

  • Genetic Heterogeneity of Borrelia burgdorferi in the United States

    D. A. Mathiesen;J. H. Oliver;C. P. Kolbert;E. D. Tullson

  • Serodiagnosis of Lyme Disease: Accuracy of a Two-Step Approach Using a Flagella-Based ELISA and Immunoblotting

    Barbara J. B. Johnson;Kenneth E. Robbins;Raymond E. Bailey;Bo-Liang Cao

  • Resistance to Lyme disease in decorin-deficient mice

    Eric L. Brown;R. Mark Wooten;Barbara J.B. Johnson;Renato V. Iozzo

  • Detection of Borrelia burgdorferi in ticks by species-specific amplification of the flagellin gene.

    Barbara J. B. Johnson;Christine M. Happ;Leonard W. Mayer;Joseph Piesman

  • Partial nucleotide sequence of St. Louis encephalitis virus RNA: Structural proteins, NS1, ns2a, and ns2b

    Dennis W. Trent;Richard M. Kinney;Barbara J.B. Johnson;A.Vance Vorndam

Frequent Co-Authors

Joseph Piesman
Joseph Piesman Centers for Disease Control and Prevention
Dennis W. Trent
Dennis W. Trent The University of Texas Medical Branch at Galveston
John T. Roehrig
John T. Roehrig Centers for Disease Control and Prevention
Richard M. Kinney
Richard M. Kinney Centers for Disease Control and Prevention
Gary P. Wormser
Gary P. Wormser New York Medical College
Bettina Wilske
Bettina Wilske Ludwig-Maximilians-Universität München
Marc C. Dolan
Marc C. Dolan Centers for Disease Control and Prevention
Maureen Howard
Maureen Howard Stanford University
Martin E. Schriefer
Martin E. Schriefer Centers for Disease Control and Prevention
Charles Y. Chiu
Charles Y. Chiu University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to numerous related careers that often require additional specialized education. For instance, pursuing healthcare roles such as a functional medicine nurse can complement a microbiology background by focusing on patient-centered treatment and holistic health.

Moreover, for those interested in allied health fields, roles like Certified Professional Coder (CPC) offer valuable career opportunities. Understanding medical coding is essential in healthcare administration and can be explored through targeted online programs, making it an accessible pathway for microbiology graduates (cpc).

Additionally, related degrees can be tailored to people with diverse backgrounds or circumstances. For example, many institutions offer flexible options for degrees felons can get, highlighting the availability of pathways to advance education and careers regardless of past challenges.

For those drawn to child development and psychology, careers such as a child.life specialist salary pathways offer rewarding opportunities that can integrate knowledge from microbiology, especially in fields focused on pediatric health and wellness.

Best Scientists Citing Barbara J. B. Johnson

Trending Scientists

Recently Published Articles